瀏覽海報時間

MP04-01: Interim single-hospital experience of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer

MP04-02: Preliminary single-hospital experience of androgen receptor pathway inhibitors for non-metastatic castration-resistant prostate cancer

MP04-03: Exploring healthcare policies: A comprehensive analysis of the 24-month medication restrictions for mHSPC

MP04-04: Preoperative androgen deprivation therapy for radical prostatectomy and short-term oncological outcomes

MP04-05: The prognostic value of biochemical markers in Radium-223 treated metastatic castration-resistant prostate cancer patients

MP04-06: The early oncological outcome of neoadjuvant androgen deprivation therapy before radical prostatectomy – a single-center experience and literature review

MP04-07: Comparison of transperineal software-assisted fusion prostate biopsy and transperineal cognitive fusion prostate biopsy

MP04-08: Prognostic factors of metastatic castration-sensitive prostate cancer(mCSPC) patients under novel hormonal agents (NHAs) treatment: A retrospective study

MP04-09: Detectability of prostate cancer using 3-Tesla Magnetic Resonance Imaging during Transperineal fusion prostate biopsy

MP04-10: How does MRI affect prebiopsy for prostatectomy upgrade rate?